{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:52:33Z","timestamp":1790635953343,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004346","name":"Stiftung Rheinland-Pfalz f\u00fcr Innovation","doi-asserted-by":"publisher","award":["AZ 961-386261\/733"],"award-info":[{"award-number":["AZ 961-386261\/733"]}],"id":[{"id":"10.13039\/501100004346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024099","name":"PHILIPS Medical Systems","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100024099","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["BMBF 01EO1503"],"award-info":[{"award-number":["BMBF 01EO1503"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Anti-retinal autoantibodies are assumed to be associated with age-related macular degeneration (AMD). To our knowledge, this is the first evaluation of autoantibodies in human sera of participants with different stages of AMD in a large population-based, observational cohort study in Germany.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Gutenberg Health Study (GHS) is a population-based, observational cohort study in Germany, including 15,010 participants aged between 35 and 74. Amongst others, non-mydriatic fundus photography (Visucam PRO NM\u2122, Carl Zeiss Meditec AG, Jena, Germany) was performed. Fundus images of the first 5000 participants were graded based on the Rotterdam Eye Study classification. Sera of participants with AMD (<jats:italic>n<\/jats:italic>=541) and sera of age-matched participants without AMD (<jats:italic>n<\/jats:italic>=490) were analyzed by antigen-microarrays. Besides descriptive statistics, autoantibody-levels were compared by Mann-Whitney-U test and the associations of level of autoantibodies with AMD were calculated by logistic regression analysis. Likewise, possible associations of the autoantibodies and both clinical and laboratory parameters on AMD subjects were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Autoantibodies against transferrin (<jats:italic>p<\/jats:italic>&lt;0.001) were significantly downregulated in participants with early AMD and soft, distinct drusen (\u226563 \u03bcm) or pigmentary abnormalities only compared to Controls. Mitogen-activated protein kinase 3 (<jats:italic>p<\/jats:italic>=0.041), glutathione peroxidase 4 (<jats:italic>p<\/jats:italic>=0.048), clusterin (<jats:italic>p<\/jats:italic>=0.045), lysozyme (<jats:italic>p<\/jats:italic>=0.19), protein kinase C substrate 80K-H (<jats:italic>p<\/jats:italic>=0.02), heat shock 70 kDa protein 1A (<jats:italic>p<\/jats:italic>=0.04) and insulin (<jats:italic>p<\/jats:italic>=0.018) show a trend between Control and participants with early AMD and soft, distinct drusen (\u226563 \u03bcm) or pigmentary abnormalities only.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study contributes to a growing knowledge of autoantibodies in association with different AMD stages compared to controls in the context of a large population-based study in Germany. Especially autoantibodies against inflammatory proteins were downregulated in participants with early AMD and soft, distinct drusen (\u226563 \u03bcm) or pigmentary abnormalities only.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00417-023-06085-2","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T05:20:55Z","timestamp":1683782455000},"page":"2763-2773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of autoantibody levels with different stages of age-related macular degeneration (AMD): Results from the population-based Gutenberg Health Study (GHS)"],"prefix":"10.1007","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7572-4749","authenticated-orcid":false,"given":"Christina A.","family":"Korb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander K.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nickels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Beutgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp S.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred E.","family":"Beutel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Schmidtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz H.","family":"Grus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"issue":"9827","key":"6085_CR1","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","volume":"379","author":"LS Lim","year":"2012","unstructured":"Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY (2012) Age-related macular degeneration. Lancet 379(9827):1728\u20131738","journal-title":"Lancet"},{"issue":"9","key":"6085_CR2","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00417-014-2591-9","volume":"252","author":"CA Korb","year":"2014","unstructured":"Korb CA, Kottler UB, Wolfram C, Hoehn R, Schulz A, Zwiener I, Wild PS, Pfeiffer N, Mirshahi A (2014) Prevalence of age-related macular degeneration in a large European cohort: results from the population-based Gutenberg Health Study. Graefes Arch Clin Exp Ophthalmol 252(9):1403\u20131411. https:\/\/doi.org\/10.1007\/s00417-014-2591-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8302","key":"6085_CR3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0140-6736(82)92679-4","volume":"2","author":"DC Dumonde","year":"1982","unstructured":"Dumonde DC, Kasp-Grochowska E, Graham E, Sanders MD, Faure JP, de Kozak Y, van Tuyen V (1982) Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet 2(8302):787\u2013792","journal-title":"Lancet"},{"issue":"11","key":"6085_CR4","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1001\/archopht.118.11.1525","volume":"118","author":"JR Heckenlively","year":"2000","unstructured":"Heckenlively JR, Fawzi AA, Oversier J, Jordan BL, Aptsiauri N (2000) Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol 118(11):1525\u20131533","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"6085_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0169-5002(03)00239-3","volume":"41","author":"MS Savchenko","year":"2003","unstructured":"Savchenko MS, Bazhin AV, Shifrina ON, Demoura SA, Kogan EA, Chuchalin AG, Philippov PP (2003) Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy. Lung Cancer 41(3):363\u2013367","journal-title":"Lung Cancer"},{"issue":"4","key":"6085_CR6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1172\/JCI112672","volume":"78","author":"GM Galbraith","year":"1986","unstructured":"Galbraith GM, Emerson D, Fudenberg HH, Gibbs CJ, Gajdusek DC (1986) Antibodies to neurofilament protein in retinitis pigmentosa. J Clin Invest 78(4):865\u2013869. https:\/\/doi.org\/10.1172\/JCI112672","journal-title":"J Clin Invest"},{"issue":"3","key":"6085_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/BF00920033","volume":"228","author":"PL Penfold","year":"1990","unstructured":"Penfold PL, Provis JM, Furby JH, Gatenby PA, Billson FA (1990) Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 228(3):270\u2013274","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"6085_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S0161-6420(91)32252-8","volume":"98","author":"DH Gurne","year":"1991","unstructured":"Gurne DH, Tso MO, Edward DP, Ripps H (1991) Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology 98(5):602\u2013607","journal-title":"Ophthalmology"},{"issue":"3","key":"6085_CR9","first-page":"113","volume":"9","author":"H Chen","year":"1993","unstructured":"Chen H, Wu L, Pan S, Wu DZ (1993) An immunologic study on age-related macular degeneration. Yan Ke Xue Bao 9(3):113\u2013120","journal-title":"Yan Ke Xue Bao"},{"issue":"6","key":"6085_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1442-9071.2006.01281.x","volume":"34","author":"S Cherepanoff","year":"2006","unstructured":"Cherepanoff S, Mitchell P, Wang JJ, Gillies MC (2006) Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the Blue Mountains Eye Study. Clin Experiment Ophthalmol 34(6):590\u2013595. https:\/\/doi.org\/10.1111\/j.1442-9071.2006.01281.x","journal-title":"Clin Experiment Ophthalmol"},{"key":"6085_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1471-2415-14-154","volume":"14","author":"G Adamus","year":"2014","unstructured":"Adamus G, Chew EY, Ferris FL, Klein ML (2014) Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration. BMC Ophthalmol 14:154. https:\/\/doi.org\/10.1186\/1471-2415-14-154","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"6085_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.yexmp.2012.03.007","volume":"93","author":"K Morohoshi","year":"2012","unstructured":"Morohoshi K, Ohbayashi M, Patel N, Chong V, Bird AC, Ono SJ (2012) Identification of anti-retinal antibodies in patients with age-related macular degeneration. Exp Mol Pathol 93(2):193\u2013199. https:\/\/doi.org\/10.1016\/j.yexmp.2012.03.007","journal-title":"Exp Mol Pathol"},{"issue":"5","key":"6085_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00417-006-0429-9","volume":"245","author":"SC Joachim","year":"2007","unstructured":"Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH (2007) Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with \"wet\" age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245(5):619\u2013626. https:\/\/doi.org\/10.1007\/s00417-006-0429-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6-7","key":"6085_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s00103-012-1502-7","volume":"55","author":"PS Wild","year":"2012","unstructured":"Wild PS, Zeller T, Beutel M, Blettner M, Dugi KA, Lackner KJ, Pfeiffer N, Munzel T, Blankenberg S (2012) The Gutenberg Health Study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55(6-7):824\u2013829. https:\/\/doi.org\/10.1007\/s00103-012-1502-7","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"3","key":"6085_CR15","doi-asserted-by":"publisher","first-page":"e0120476","DOI":"10.1371\/journal.pone.0120476","volume":"10","author":"R H\u00f6hn","year":"2015","unstructured":"H\u00f6hn R, Kottler U, Peto T, Blettner M, Munzel T, Blankenberg S, Lackner KJ, Beutel M, Wild PS, Pfeiffer N (2015) The Ophthalmic Branch of the Gutenberg Health Study: Study Design, Cohort Profile and Self-Reported Diseases. PloS One 10(3):e0120476. https:\/\/doi.org\/10.1371\/journal.pone.0120476","journal-title":"PloS One"},{"issue":"4","key":"6085_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1001\/archopht.121.4.519","volume":"121","author":"R van Leeuwen","year":"2003","unstructured":"van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT (2003) The risk and natural course of age-related maculopathy: follow-up at 6 1\/2 years in the Rotterdam study. Arch Ophthalmol 121(4):519\u2013526. https:\/\/doi.org\/10.1001\/archopht.121.4.519","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"6085_CR17","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1167\/iovs.05-1135","volume":"47","author":"I Chowers","year":"2006","unstructured":"Chowers I, Wong R, Dentchev T, Farkas RH, Iacovelli J, Gunatilaka TL, Medeiros NE, Presley JB, Campochiaro PA, Curcio CA, Dunaief JL, Zack DJ (2006) The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 47(5):2135\u20132140. https:\/\/doi.org\/10.1167\/iovs.05-1135","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6085_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.exer.2012.10.003","volume":"106","author":"D Wysokinski","year":"2013","unstructured":"Wysokinski D, Danisz K, Blasiak J, Dorecka M, Romaniuk D, Szaflik J, Szaflik JP (2013) An association of transferrin gene polymorphism and serum transferrin levels with age-related macular degeneration. Exp Eye Res 106:14\u201323. https:\/\/doi.org\/10.1016\/j.exer.2012.10.003","journal-title":"Exp Eye Res"},{"issue":"5","key":"6085_CR19","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1167\/iovs.13-13554","volume":"55","author":"P Yang","year":"2014","unstructured":"Yang P, Baciu P, Kerrigan BC, Etheridge M, Sung E, Toimil BA, Berchuck JE, Jaffe GJ (2014) Retinal pigment epithelial cell death by the alternative complement cascade: role of membrane regulatory proteins, calcium, PKC, and oxidative stress. Invest Ophthalmol Vis Sci 55(5):3012\u20133021. https:\/\/doi.org\/10.1167\/iovs.13-13554","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"6085_CR20","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2017.12.023","volume":"125","author":"L Lores-Motta","year":"2018","unstructured":"Lores-Motta L, Paun CC, Corominas J, Pauper M, Geerlings MJ, Altay L, Schick T, Daha MR, Fauser S, Hoyng CB, den Hollander AI, de Jong EK (2018) Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration. Ophthalmology 125(7):1064\u20131074. https:\/\/doi.org\/10.1016\/j.ophtha.2017.12.023","journal-title":"Ophthalmology"},{"key":"6085_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.11.005","volume":"45","author":"SS Whitmore","year":"2015","unstructured":"Whitmore SS, Sohn EH, Chirco KR, Drack AV, Stone EM, Tucker BA, Mullins RF (2015) Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. Prog Retin Eye Res 45:1\u201329. https:\/\/doi.org\/10.1016\/j.preteyeres.2014.11.005","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"6085_CR22","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.18240\/ijo.2017.07.04","volume":"10","author":"YQ Zhang","year":"2017","unstructured":"Zhang YQ, Fan YG, Dang YL, Liu YL, Liu H, Li LH (2017) Down-regulation of protein kinase C alpha\/ezrin signals in light-induced phagocytic crisis of retinal pigment epithelium cells. Int J Ophthalmol 10(7):1040\u20131045. https:\/\/doi.org\/10.18240\/ijo.2017.07.04","journal-title":"Int J Ophthalmol"},{"issue":"11","key":"6085_CR23","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1093\/emboj\/20.11.2723","volume":"20","author":"T Ng","year":"2001","unstructured":"Ng T, Parsons M, Hughes WE, Monypenny J, Zicha D, Gautreau A, Arpin M, Gschmeissner S, Verveer PJ, Bastiaens PI, Parker PJ (2001) Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J 20(11):2723\u20132741. https:\/\/doi.org\/10.1093\/emboj\/20.11.2723","journal-title":"EMBO J"},{"issue":"3","key":"6085_CR24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1167\/iovs.09-4478","volume":"51","author":"JG Hollyfield","year":"2010","unstructured":"Hollyfield JG (2010) Age-related macular degeneration: the molecular link between oxidative damage, tissue-specific inflammation and outer retinal disease: the Proctor lecture. Invest Ophthalmol Vis Sci 51(3):1275\u20131281. https:\/\/doi.org\/10.1167\/iovs.09-4478","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6085_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4137\/OED.S32200","volume":"8","author":"SV Kyosseva","year":"2016","unstructured":"Kyosseva SV (2016) Targeting MAPK Signaling in Age-Related Macular Degeneration. Ophthalmol Eye Dis 8:23\u201330. https:\/\/doi.org\/10.4137\/OED.S32200","journal-title":"Ophthalmol Eye Dis"},{"issue":"3","key":"6085_CR26","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/ijms16035789","volume":"16","author":"CM Chan","year":"2015","unstructured":"Chan CM, Huang CH, Li HJ, Hsiao CY, Su CC, Lee PL, Hung CF (2015) Protective effects of resveratrol against UVA-induced damage in ARPE19 cells. Int J Mol Sci 16(3):5789\u20135802. https:\/\/doi.org\/10.3390\/ijms16035789","journal-title":"Int J Mol Sci"},{"issue":"1-4","key":"6085_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/biof.5520170128","volume":"17","author":"M Torres","year":"2003","unstructured":"Torres M, Forman HJ (2003) Redox signaling and the MAP kinase pathways. Biofactors 17(1-4):287\u2013296","journal-title":"Biofactors"},{"issue":"8","key":"6085_CR28","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3109\/02713683.2014.961613","volume":"40","author":"S Koinzer","year":"2015","unstructured":"Koinzer S, Reinecke K, Herdegen T, Roider J, Klettner A (2015) Oxidative Stress Induces Biphasic ERK1\/2 Activation in the RPE with Distinct Effects on Cell Survival at Early and Late Activation. Curr Eye Res 40(8):853\u2013857. https:\/\/doi.org\/10.3109\/02713683.2014.961613","journal-title":"Curr Eye Res"},{"issue":"34","key":"6085_CR29","doi-asserted-by":"publisher","first-page":"13781","DOI":"10.1073\/pnas.1206494109","volume":"109","author":"S Dridi","year":"2012","unstructured":"Dridi S, Hirano Y, Tarallo V, Kim Y, Fowler BJ, Ambati BK, Bogdanovich S, Chiodo VA, Hauswirth WW, Kugel JF, Goodrich JA, Ponicsan SL, Hinton DR, Kleinman ME, Baffi JZ, Gelfand BD, Ambati J (2012) ERK1\/2 activation is a therapeutic target in age-related macular degeneration. Proc Natl Acad Sci U S A 109(34):13781\u201313786. https:\/\/doi.org\/10.1073\/pnas.1206494109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6085_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.exer.2016.05.012","volume":"147","author":"G Adamus","year":"2016","unstructured":"Adamus G, Yang S, Weleber RG (2016) Unique epitopes for carbonic anhydrase II autoantibodies related to autoimmune retinopathy and cancer-associated retinopathy. Exp Eye Res 147:161\u2013168. https:\/\/doi.org\/10.1016\/j.exer.2016.05.012","journal-title":"Exp Eye Res"},{"issue":"5","key":"6085_CR31","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.autrev.2009.01.002","volume":"8","author":"G Adamus","year":"2009","unstructured":"Adamus G (2009) Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev 8(5):410\u2013414. https:\/\/doi.org\/10.1016\/j.autrev.2009.01.002","journal-title":"Autoimmun Rev"},{"issue":"2","key":"6085_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jaut.2009.02.001","volume":"32","author":"G Adamus","year":"2009","unstructured":"Adamus G, Karren L (2009) Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy. J Autoimmun 32(2):133\u2013139. https:\/\/doi.org\/10.1016\/j.jaut.2009.02.001","journal-title":"J Autoimmun"},{"issue":"1","key":"6085_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00006676-200307000-00004","volume":"27","author":"T Taniguchi","year":"2003","unstructured":"Taniguchi T, Okazaki K, Okamoto M, Seko S, Tanaka J, Uchida K, Nagashima K, Kurose T, Yamada Y, Chiba T, Seino Y (2003) High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in type 1 diabetes: concept of autoimmune exocrinopathy and endocrinopathy of the pancreas. Pancreas 27(1):26\u201330","journal-title":"Pancreas"},{"issue":"1-2","key":"6085_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jaut.2012.03.001","volume":"39","author":"VK Bournia","year":"2012","unstructured":"Bournia VK, Vlachoyiannopoulos PG (2012) Subgroups of Sjogren syndrome patients according to serological profiles. J Autoimmun 39(1-2):15\u201326. https:\/\/doi.org\/10.1016\/j.jaut.2012.03.001","journal-title":"J Autoimmun"},{"issue":"1","key":"6085_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/art.1780350112","volume":"35","author":"Y Itoh","year":"1992","unstructured":"Itoh Y, Reichlin M (1992) Antibodies to carbonic anhydrase in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 35(1):73\u201382","journal-title":"Arthritis Rheum"},{"issue":"1","key":"6085_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s40135-013-0037-x","volume":"2","author":"PA Frederick","year":"2014","unstructured":"Frederick PA, Kleinman ME (2014) The Immune System and AMD. Curr Ophthalmol Rep 2(1):14\u201319. https:\/\/doi.org\/10.1007\/s40135-013-0037-x","journal-title":"Curr Ophthalmol Rep"},{"issue":"3","key":"6085_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000085533","volume":"37","author":"R Sarangarajan","year":"2005","unstructured":"Sarangarajan R, Apte SP (2005) Melanin aggregation and polymerization: possible implications in age-related macular degeneration. Ophthalmic Res 37(3):136\u2013141. https:\/\/doi.org\/10.1159\/000085533","journal-title":"Ophthalmic Res"},{"key":"6085_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.preteyeres.2013.07.003","volume":"37","author":"D Ardeljan","year":"2013","unstructured":"Ardeljan D, Chan CC (2013) Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res 37:68\u201389. https:\/\/doi.org\/10.1016\/j.preteyeres.2013.07.003","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"6085_CR39","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1167\/iovs.10-5881","volume":"51","author":"AW Stitt","year":"2010","unstructured":"Stitt AW (2010) AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 51(10):4867\u20134874. https:\/\/doi.org\/10.1167\/iovs.10-5881","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"6085_CR40","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1167\/iovs.04-0404","volume":"45","author":"KA Howes","year":"2004","unstructured":"Howes KA, Liu Y, Dunaief JL, Milam A, Frederick JM, Marks A, Baehr W (2004) Receptor for advanced glycation end products and age-related macular degeneration. Invest Ophthalmol Vis Sci 45(10):3713\u20133720. https:\/\/doi.org\/10.1167\/iovs.04-0404","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"6085_CR41","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4161\/auto.24546","volume":"9","author":"K Kaarniranta","year":"2013","unstructured":"Kaarniranta K, Sinha D, Blasiak J, Kauppinen A, Vereb Z, Salminen A, Boulton ME, Petrovski G (2013) Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration. Autophagy 9(7):973\u2013984. https:\/\/doi.org\/10.4161\/auto.24546","journal-title":"Autophagy"},{"key":"6085_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.preteyeres.2015.09.002","volume":"51","author":"DA Ferrington","year":"2016","unstructured":"Ferrington DA, Sinha D, Kaarniranta K (2016) Defects in retinal pigment epithelial cell proteolysis and the pathology associated with age-related macular degeneration. Prog Retin Eye Res 51:69\u201389. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.09.002","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"6085_CR43","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1365-2567.2005.02173.x","volume":"115","author":"N Patel","year":"2005","unstructured":"Patel N, Ohbayashi M, Nugent AK, Ramchand K, Toda M, Chau KY, Bunce C, Webster A, Bird AC, Ono SJ, Chong V (2005) Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 115(3):422\u2013430. https:\/\/doi.org\/10.1111\/j.1365-2567.2005.02173.x","journal-title":"Immunology"},{"issue":"3-4","key":"6085_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jaut.2009.09.003","volume":"33","author":"K Morohoshi","year":"2009","unstructured":"Morohoshi K, Goodwin AM, Ohbayashi M, Ono SJ (2009) Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J Autoimmun 33(3-4):247\u2013254. https:\/\/doi.org\/10.1016\/j.jaut.2009.09.003","journal-title":"J Autoimmun"},{"issue":"3","key":"6085_CR45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.autrev.2017.01.005","volume":"16","author":"G Adamus","year":"2017","unstructured":"Adamus G (2017) Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration? Autoimmun Rev 16(3):231\u2013236. https:\/\/doi.org\/10.1016\/j.autrev.2017.01.005","journal-title":"Autoimmun Rev"},{"issue":"5","key":"6085_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11926-014-0419-6","volume":"16","author":"KD Deane","year":"2014","unstructured":"Deane KD (2014) Preclinical rheumatoid arthritis (autoantibodies): an updated review. Curr Rheumatol Rep 16(5):419. https:\/\/doi.org\/10.1007\/s11926-014-0419-6","journal-title":"Curr Rheumatol Rep"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06085-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-023-06085-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06085-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T06:04:35Z","timestamp":1696053875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-023-06085-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6085"],"URL":"https:\/\/doi.org\/10.1007\/s00417-023-06085-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and study documents were approved by the local ethics committee of the Medical Chamber of Rhineland-Palatinate, Germany (reference no. 837.020.07; original vote: 22.3.2007, latest update: 20.10.2015). According to the tenets of the Declaration of Helsinki, written informed consent was obtained from all participants prior to entering the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}